ENCEFALOMIELITIS AUTOINMUNE EXPERIMENTAL PDF
Br J Pharmacol. Oct;(4) doi: /j x. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple. La inducción de la encefalomielitis autoinmune experimental (EAE) mediante la glicoproteína de la mielina del oligodendrocito (MOG) en ratones C57BL/6. Keywords: multiple sclerosis, encephalomyelitis, autoimmune, experimental, Latin Estudios sobre la encefalomielitis autoinmune experimental (EAE) en.
|Published (Last):||9 October 2014|
|PDF File Size:||4.32 Mb|
|ePub File Size:||15.82 Mb|
|Price:||Free* [*Free Regsitration Required]|
Repita el paso de lavado. The entry of autoreactive T cells into the central nervous system, together with other inflammatory mediators, is facilitated by an increase in vascular permeability at the blood-brain barrier, contributing to the demyelination and axonal loss typical of EAE and MS . According to the results, the diseased animals exhibited increased levels of IL mRNA, in agreement with the data published by other authors working on this model .
Repetir la etapa de lavado con l de PBS. Experimental autoimmune encephalomyelitis EAE is the most commonly used experimental model for the human inflammatory demyelinating disease, multiple sclerosis MS.
This procedure is not equally successful with every animal species, however —especially when using myelin oligodendrocyte glycoprotein MOG for this purpose— due to variations in genetic background and allele polymorphisms of class II histocompatibility complex molecules and T-cell receptors .
Este curso se divide en tres fases: From Wikipedia, the free encyclopedia. Cause and prevention of demyelination in a model multiple sclerosis lesion, 22 FebruaryDOI: However, its contribution to this endeavor is controversial: A misleading model of Multiple Sclerosis”. One of them is motor deterioration, which may compromise access of the affected individuals to the food placed in their boxes. EAE can be induced in a number of species, including mice, rats, guinea pigs, rabbits and primates.
The immunological basis for treatment of multiple sclerosis. Instances have been described, to cite one example, where experimental animals have become completely impervious to the induction of EAE depending, solely, on the particular facilities or animal handling procedures employed during the experiment . While creating difficulties and underscoring the inherent weaknesses of this model of MS in straightforward translation from EAE to the human disease, this variability also creates an opportunity to explore multiple facets of the immune and neural mechanisms of immune-mediated neuroinflammation and demyelination as well as intrinsic protective mechanisms.
In the past 20 years, researchers have used transgenic techniques to develop new versions of the model and to expand its utility. Baker and his colleague Sandra Amor at VU University Medical Center in the Netherlands laid out a set of guidelines that proposes minimally acceptable standards for publishing studies that use EAE as a preclinical model Baker and Amor, Preparation of the antigen for inducing EAE FIA plus MT The contents of one ampoule of MT mg were transferred into a small mortar and the yellowish bacterial aggregates were ground into a whitish fine powder and then mixed under continuous agitation with As the most widely used model system for studying MS, with many variations see above for types of variationit offers an array of possibilities for matching an experimental question with a physiological profile.
EAE is usually induced in susceptible animal species by immunization with myelin sheath antigens.
Nat Rev Drug Discov. There is great heterogeneity in the susceptibility to the induction, the method of induction and the response to various immunological or neuropharmacological interventions, many of which are reviewed here. Retrieved from ” https: Probar la especificidad de cada cebador. The specific pathological features vary dramatically depending on the animal, genetic strain, induction method, and autoantigen used Miller and Karpus, ; Pachner ; Baxter In the course of his experiments, the researcher, Thomas Rivers, injected control animals with emulsified brain tissue; they developed brain-specific antibodies and a proportion of them became transiently paralyzed.
In many protocols, mice are coinjected with pertussis toxin to break down the blood-brain barrier and allow immune cells access to the CNS tissue.
Los pares de cebadores. In the negative control group, body weight increased steadily throughout the study, at a rate above that of diseased animals.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
EAE is also the go-to model for testing the effectiveness of potential MS therapeutics. There is data pointing to Th17 cells as effectors in this disorder .
Demyelination is produced by injection of brain encefalomielitia, CNS proteins such as myelin basic proteinor peptides from such protein emulsified in an adjuvant such as complete Freund’s adjuvant.
Today, however, most researchers use mice—and two strains in particular power the bulk of EAE studies. This is a relatively early onset within the range of days post-induction described by other authors [26, 27]. IL drives a pathogenic T cell population that induces autoimmune inflammation. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
DeCS Server – List Exact Term
Epub Jun Epub Apr Additionally, unlike most EAE models, in which T cell responses drive pathology, B cell activation in these animals contributes significantly to disease development. The model for primary progressive MS is the Theiler’s virus model. The results indicate that the model has clinical value, and can be used to establish an adequate correlation for preclinical studies of new drugs against MS.
Part of the experimmental, he says, stems from the nature of the experimental manipulations: In diseased animals, clinical signs started to appear by day 8 post-induction. All tests used 0. Experimental autoimmune encephalomyelitis in the mouse.
The maximum clinical score of the diseased animals reached high values during the development of EAE, and there was correspondence between clinical signs, the results of molecular assays and the encecalomielitis ultrastructural modifications, which consisted mainly of demyelination and axonal damage at the spinal cord.
In this case, this variable would constitute a correlate of disease severity. A six-point scale reflects the severity of symptoms, with a score of 1 being tail paralysis, a score of 4 indicating quadriplegia, and a score of 5 defined as death. Figure 1C shows the maximum indexes reached by each animal on the clinical scale.
An average clinical index was calculated for each group based on the individual scores, and the maximum clinical index for each animal during the study was also determined.